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Introduction
Classification criteria are needed to aid recruitment of
appropriate patients into research studies. The Interna-
tional Myositis Classification Criteria Project (IMCCP)
was set up with support from ACR and EULAR.
Objectives
To develop and validate new classification criteria for adult
and juvenile IIM.
Methods
Candidate criteria variables were taken from published cri-
teria and inclusion criteria from clinical trials of myositis.
Comparator groups confused with IIM were defined. Clin-
ical and laboratory data from IIM and comparator patients
were collected from 47 rheumatology, dermatology, neu-
rology and pediatrics clinics worldwide from 2008-2011.
Pair-wise associations among all items and between
each item and clinicians’ diagnoses were assessed. Three
approaches for derivation of classification criteria were
explored: Traditional, Probability score and Classification
tree.
Internal validation using bootstrap methods and exter-
nal validation using data from the Euromyositis register
and the Juvenile Dermatomyositis cohort biomarker
study and repository UK and Ireland was performed.
Results
976 IIM (74% adults; 26% children) and 624 comparators
(81% adults; 19% children) were obtained.
The new criteria comprise clinical items on muscles,
skin, and laboratory measures. Muscle biopsy features
can be included. Each item has an assigned score, the
total score corresponds to the probability of having IIM.
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Table 1 Performance of new and exisiting classification / diagnostic criteria for idiopathic inflammatory myopathies
Performance
(%)














Sensitivity 91 94 98 96 93 6 51
Specificity 82 85 55 31 88 99 96
Correctly
classified
88 91 86 79 91 45 70
a Cut point for probability: 55%
b Definite and probable polymyositis and dermatomyositis
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Each probability has specific sensitivity/specificity mea-
sures making it possible to use individual inclusion cri-
teria for clinical studies. If no skin rash is present a
muscle biopsy is mandatory. High probability of IIM is
considered if the score > 7.5 (or > 8.7 if no skin rash),
with minimum probability cutoff of 50% (score 5.3 or
6.5). Table 1.
External validation using data on 592 adult or 332
juvenile IIM patients yielded 100% sensitivity.
Conclusion
The new classification criteria for IIM have easy-to-
access items and show generally superior performance
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